nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—ABCC1—Progesterone—uterine cancer	0.0925	0.115	CbGbCtD
Indinavir—ABCC1—Dactinomycin—uterine cancer	0.0733	0.0913	CbGbCtD
Indinavir—SLC22A1—Progesterone—uterine cancer	0.0728	0.0906	CbGbCtD
Indinavir—ABCC1—Epirubicin—uterine cancer	0.0531	0.0661	CbGbCtD
Indinavir—CYP3A7-CYP3A51P—Progesterone—uterine cancer	0.0457	0.0569	CbGbCtD
Indinavir—CYP3A7—Progesterone—uterine cancer	0.0457	0.0569	CbGbCtD
Indinavir—ABCC1—Etoposide—uterine cancer	0.0414	0.0515	CbGbCtD
Indinavir—ABCC2—Carboplatin—uterine cancer	0.0365	0.0454	CbGbCtD
Indinavir—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0347	0.0432	CbGbCtD
Indinavir—CYP3A5—Progesterone—uterine cancer	0.0343	0.0427	CbGbCtD
Indinavir—ABCC2—Etoposide—uterine cancer	0.0306	0.0381	CbGbCtD
Indinavir—ABCC1—Doxorubicin—uterine cancer	0.0282	0.0351	CbGbCtD
Indinavir—CYP2C19—Progesterone—uterine cancer	0.0277	0.0344	CbGbCtD
Indinavir—CYP2C9—Progesterone—uterine cancer	0.023	0.0286	CbGbCtD
Indinavir—ABCB1—Progesterone—uterine cancer	0.0223	0.0278	CbGbCtD
Indinavir—CYP2D6—Progesterone—uterine cancer	0.021	0.0262	CbGbCtD
Indinavir—ABCC2—Doxorubicin—uterine cancer	0.0209	0.026	CbGbCtD
Indinavir—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0202	0.0251	CbGbCtD
Indinavir—ABCB1—Dactinomycin—uterine cancer	0.0177	0.022	CbGbCtD
Indinavir—CYP3A5—Etoposide—uterine cancer	0.0153	0.0191	CbGbCtD
Indinavir—CYP3A4—Progesterone—uterine cancer	0.0134	0.0166	CbGbCtD
Indinavir—ABCB1—Etoposide—uterine cancer	0.00999	0.0124	CbGbCtD
Indinavir—ABCB1—Doxorubicin—uterine cancer	0.00681	0.00848	CbGbCtD
Indinavir—CYP2D6—Doxorubicin—uterine cancer	0.00642	0.00799	CbGbCtD
Indinavir—CYP3A4—Etoposide—uterine cancer	0.00598	0.00745	CbGbCtD
Indinavir—CYP3A4—Doxorubicin—uterine cancer	0.00408	0.00508	CbGbCtD
Indinavir—Saquinavir—CYP11A1—uterine cancer	0.00248	1	CrCbGaD
Indinavir—SLCO1B1—renal system—uterine cancer	0.000225	0.0538	CbGeAlD
Indinavir—ABCC1—myometrium—uterine cancer	0.000206	0.0493	CbGeAlD
Indinavir—Eye pain—Doxorubicin—uterine cancer	0.000203	0.00109	CcSEcCtD
Indinavir—Nausea—Progesterone—uterine cancer	0.000202	0.00108	CcSEcCtD
Indinavir—Renal failure acute—Doxorubicin—uterine cancer	0.000198	0.00107	CcSEcCtD
Indinavir—Pain in extremity—Epirubicin—uterine cancer	0.000198	0.00107	CcSEcCtD
Indinavir—Feeling abnormal—Dactinomycin—uterine cancer	0.000198	0.00106	CcSEcCtD
Indinavir—Ill-defined disorder—Etoposide—uterine cancer	0.000197	0.00106	CcSEcCtD
Indinavir—Anaemia—Etoposide—uterine cancer	0.000197	0.00106	CcSEcCtD
Indinavir—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000196	0.00106	CcSEcCtD
Indinavir—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000196	0.00105	CcSEcCtD
Indinavir—Increased appetite—Doxorubicin—uterine cancer	0.000195	0.00105	CcSEcCtD
Indinavir—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000194	0.00104	CcSEcCtD
Indinavir—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000194	0.00104	CcSEcCtD
Indinavir—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000193	0.00104	CcSEcCtD
Indinavir—Renal impairment—Doxorubicin—uterine cancer	0.000193	0.00104	CcSEcCtD
Indinavir—Malaise—Etoposide—uterine cancer	0.000192	0.00103	CcSEcCtD
Indinavir—Vertigo—Etoposide—uterine cancer	0.000191	0.00103	CcSEcCtD
Indinavir—SLC22A1—renal system—uterine cancer	0.00019	0.0454	CbGeAlD
Indinavir—Abdominal pain—Dactinomycin—uterine cancer	0.00019	0.00102	CcSEcCtD
Indinavir—Body temperature increased—Dactinomycin—uterine cancer	0.00019	0.00102	CcSEcCtD
Indinavir—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000189	0.00102	CcSEcCtD
Indinavir—Loss of consciousness—Etoposide—uterine cancer	0.000187	0.00101	CcSEcCtD
Indinavir—Cough—Etoposide—uterine cancer	0.000186	0.000999	CcSEcCtD
Indinavir—Blood creatinine increased—Epirubicin—uterine cancer	0.000186	0.000998	CcSEcCtD
Indinavir—Pain in extremity—Doxorubicin—uterine cancer	0.000183	0.000986	CcSEcCtD
Indinavir—SLCO1A2—renal system—uterine cancer	0.000183	0.0437	CbGeAlD
Indinavir—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000183	0.000983	CcSEcCtD
Indinavir—Dry skin—Epirubicin—uterine cancer	0.000182	0.000976	CcSEcCtD
Indinavir—Chest pain—Etoposide—uterine cancer	0.000181	0.000974	CcSEcCtD
Indinavir—SLCO1B1—female reproductive system—uterine cancer	0.00018	0.0431	CbGeAlD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00018	0.000967	CcSEcCtD
Indinavir—Discomfort—Etoposide—uterine cancer	0.000179	0.000963	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000178	0.000959	CcSEcCtD
Indinavir—Hypersensitivity—Dactinomycin—uterine cancer	0.000177	0.000951	CcSEcCtD
Indinavir—Gastritis—Epirubicin—uterine cancer	0.000175	0.000943	CcSEcCtD
Indinavir—Muscular weakness—Epirubicin—uterine cancer	0.000175	0.000939	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000175	0.000939	CcSEcCtD
Indinavir—Anaphylactic shock—Etoposide—uterine cancer	0.000174	0.000934	CcSEcCtD
Indinavir—Abdominal distension—Epirubicin—uterine cancer	0.000172	0.000927	CcSEcCtD
Indinavir—Asthenia—Dactinomycin—uterine cancer	0.000172	0.000926	CcSEcCtD
Indinavir—Blood creatinine increased—Doxorubicin—uterine cancer	0.000172	0.000923	CcSEcCtD
Indinavir—ABCC2—renal system—uterine cancer	0.00017	0.0408	CbGeAlD
Indinavir—Thrombocytopenia—Etoposide—uterine cancer	0.00017	0.000914	CcSEcCtD
Indinavir—Skin disorder—Etoposide—uterine cancer	0.000169	0.000907	CcSEcCtD
Indinavir—Dry skin—Doxorubicin—uterine cancer	0.000168	0.000903	CcSEcCtD
Indinavir—Hyperhidrosis—Etoposide—uterine cancer	0.000168	0.000903	CcSEcCtD
Indinavir—Pancreatitis—Epirubicin—uterine cancer	0.000168	0.000903	CcSEcCtD
Indinavir—Angina pectoris—Epirubicin—uterine cancer	0.000167	0.000897	CcSEcCtD
Indinavir—Anorexia—Etoposide—uterine cancer	0.000166	0.00089	CcSEcCtD
Indinavir—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000165	0.000887	CcSEcCtD
Indinavir—Diarrhoea—Dactinomycin—uterine cancer	0.000164	0.000883	CcSEcCtD
Indinavir—Gastritis—Doxorubicin—uterine cancer	0.000162	0.000872	CcSEcCtD
Indinavir—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000162	0.000869	CcSEcCtD
Indinavir—Muscular weakness—Doxorubicin—uterine cancer	0.000162	0.000869	CcSEcCtD
Indinavir—ABCC1—uterine cervix—uterine cancer	0.00016	0.0384	CbGeAlD
Indinavir—Dysuria—Epirubicin—uterine cancer	0.00016	0.000861	CcSEcCtD
Indinavir—Abdominal distension—Doxorubicin—uterine cancer	0.000159	0.000857	CcSEcCtD
Indinavir—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000159	0.000856	CcSEcCtD
Indinavir—Pollakiuria—Epirubicin—uterine cancer	0.000158	0.00085	CcSEcCtD
Indinavir—Paraesthesia—Etoposide—uterine cancer	0.000156	0.000839	CcSEcCtD
Indinavir—Weight increased—Epirubicin—uterine cancer	0.000156	0.000838	CcSEcCtD
Indinavir—Pancreatitis—Doxorubicin—uterine cancer	0.000155	0.000835	CcSEcCtD
Indinavir—Dyspnoea—Etoposide—uterine cancer	0.000155	0.000833	CcSEcCtD
Indinavir—Hyperglycaemia—Epirubicin—uterine cancer	0.000154	0.00083	CcSEcCtD
Indinavir—Somnolence—Etoposide—uterine cancer	0.000154	0.00083	CcSEcCtD
Indinavir—Angina pectoris—Doxorubicin—uterine cancer	0.000154	0.00083	CcSEcCtD
Indinavir—Pneumonia—Epirubicin—uterine cancer	0.000153	0.000826	CcSEcCtD
Indinavir—ABCC1—decidua—uterine cancer	0.000153	0.0366	CbGeAlD
Indinavir—Vomiting—Dactinomycin—uterine cancer	0.000153	0.00082	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000151	0.000814	CcSEcCtD
Indinavir—Rash—Dactinomycin—uterine cancer	0.000151	0.000814	CcSEcCtD
Indinavir—Decreased appetite—Etoposide—uterine cancer	0.000151	0.000812	CcSEcCtD
Indinavir—Renal failure—Epirubicin—uterine cancer	0.00015	0.000807	CcSEcCtD
Indinavir—Gastrointestinal disorder—Etoposide—uterine cancer	0.00015	0.000806	CcSEcCtD
Indinavir—Fatigue—Etoposide—uterine cancer	0.00015	0.000805	CcSEcCtD
Indinavir—Neuropathy peripheral—Epirubicin—uterine cancer	0.00015	0.000805	CcSEcCtD
Indinavir—Jaundice—Epirubicin—uterine cancer	0.000149	0.0008	CcSEcCtD
Indinavir—Constipation—Etoposide—uterine cancer	0.000148	0.000799	CcSEcCtD
Indinavir—Pain—Etoposide—uterine cancer	0.000148	0.000799	CcSEcCtD
Indinavir—Urinary tract infection—Epirubicin—uterine cancer	0.000148	0.000798	CcSEcCtD
Indinavir—Dysuria—Doxorubicin—uterine cancer	0.000148	0.000796	CcSEcCtD
Indinavir—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000147	0.000792	CcSEcCtD
Indinavir—Sweating—Epirubicin—uterine cancer	0.000146	0.000787	CcSEcCtD
Indinavir—Pollakiuria—Doxorubicin—uterine cancer	0.000146	0.000787	CcSEcCtD
Indinavir—Haematuria—Epirubicin—uterine cancer	0.000146	0.000783	CcSEcCtD
Indinavir—ABCC1—endometrium—uterine cancer	0.000145	0.0347	CbGeAlD
Indinavir—Hepatobiliary disease—Epirubicin—uterine cancer	0.000144	0.000776	CcSEcCtD
Indinavir—Weight increased—Doxorubicin—uterine cancer	0.000144	0.000775	CcSEcCtD
Indinavir—Sinusitis—Epirubicin—uterine cancer	0.000143	0.00077	CcSEcCtD
Indinavir—Feeling abnormal—Etoposide—uterine cancer	0.000143	0.00077	CcSEcCtD
Indinavir—Hyperglycaemia—Doxorubicin—uterine cancer	0.000143	0.000768	CcSEcCtD
Indinavir—Nausea—Dactinomycin—uterine cancer	0.000143	0.000766	CcSEcCtD
Indinavir—Pneumonia—Doxorubicin—uterine cancer	0.000142	0.000764	CcSEcCtD
Indinavir—Gastrointestinal pain—Etoposide—uterine cancer	0.000142	0.000764	CcSEcCtD
Indinavir—ABCC1—mammalian vulva—uterine cancer	0.00014	0.0336	CbGeAlD
Indinavir—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00014	0.000753	CcSEcCtD
Indinavir—Renal failure—Doxorubicin—uterine cancer	0.000139	0.000747	CcSEcCtD
Indinavir—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000138	0.000744	CcSEcCtD
Indinavir—Urticaria—Etoposide—uterine cancer	0.000138	0.000742	CcSEcCtD
Indinavir—Haemoglobin—Epirubicin—uterine cancer	0.000138	0.000741	CcSEcCtD
Indinavir—Jaundice—Doxorubicin—uterine cancer	0.000138	0.00074	CcSEcCtD
Indinavir—SLC22A1—vagina—uterine cancer	0.000138	0.0329	CbGeAlD
Indinavir—Body temperature increased—Etoposide—uterine cancer	0.000137	0.000738	CcSEcCtD
Indinavir—Abdominal pain—Etoposide—uterine cancer	0.000137	0.000738	CcSEcCtD
Indinavir—Urinary tract infection—Doxorubicin—uterine cancer	0.000137	0.000738	CcSEcCtD
Indinavir—Haemorrhage—Epirubicin—uterine cancer	0.000137	0.000737	CcSEcCtD
Indinavir—Hepatitis—Epirubicin—uterine cancer	0.000137	0.000737	CcSEcCtD
Indinavir—ABCC2—female reproductive system—uterine cancer	0.000136	0.0326	CbGeAlD
Indinavir—Hypoaesthesia—Epirubicin—uterine cancer	0.000136	0.000733	CcSEcCtD
Indinavir—Pharyngitis—Epirubicin—uterine cancer	0.000136	0.000731	CcSEcCtD
Indinavir—Sweating—Doxorubicin—uterine cancer	0.000135	0.000728	CcSEcCtD
Indinavir—Urinary tract disorder—Epirubicin—uterine cancer	0.000135	0.000728	CcSEcCtD
Indinavir—Haematuria—Doxorubicin—uterine cancer	0.000135	0.000724	CcSEcCtD
Indinavir—Connective tissue disorder—Epirubicin—uterine cancer	0.000135	0.000724	CcSEcCtD
Indinavir—Urethral disorder—Epirubicin—uterine cancer	0.000134	0.000722	CcSEcCtD
Indinavir—ABCC1—uterus—uterine cancer	0.000134	0.032	CbGeAlD
Indinavir—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000134	0.000718	CcSEcCtD
Indinavir—Sinusitis—Doxorubicin—uterine cancer	0.000132	0.000713	CcSEcCtD
Indinavir—Erythema multiforme—Epirubicin—uterine cancer	0.00013	0.000697	CcSEcCtD
Indinavir—Hypersensitivity—Etoposide—uterine cancer	0.000128	0.000688	CcSEcCtD
Indinavir—Haemoglobin—Doxorubicin—uterine cancer	0.000127	0.000685	CcSEcCtD
Indinavir—Flushing—Epirubicin—uterine cancer	0.000127	0.000684	CcSEcCtD
Indinavir—Hepatitis—Doxorubicin—uterine cancer	0.000127	0.000682	CcSEcCtD
Indinavir—Haemorrhage—Doxorubicin—uterine cancer	0.000127	0.000682	CcSEcCtD
Indinavir—Hypoaesthesia—Doxorubicin—uterine cancer	0.000126	0.000678	CcSEcCtD
Indinavir—Pharyngitis—Doxorubicin—uterine cancer	0.000126	0.000677	CcSEcCtD
Indinavir—Urinary tract disorder—Doxorubicin—uterine cancer	0.000125	0.000673	CcSEcCtD
Indinavir—Asthenia—Etoposide—uterine cancer	0.000125	0.00067	CcSEcCtD
Indinavir—Connective tissue disorder—Doxorubicin—uterine cancer	0.000125	0.00067	CcSEcCtD
Indinavir—Urethral disorder—Doxorubicin—uterine cancer	0.000124	0.000668	CcSEcCtD
Indinavir—Immune system disorder—Epirubicin—uterine cancer	0.000124	0.000666	CcSEcCtD
Indinavir—CYP3A5—uterine cervix—uterine cancer	0.000123	0.0295	CbGeAlD
Indinavir—Chills—Epirubicin—uterine cancer	0.000123	0.000661	CcSEcCtD
Indinavir—Pruritus—Etoposide—uterine cancer	0.000123	0.000661	CcSEcCtD
Indinavir—Alopecia—Epirubicin—uterine cancer	0.000121	0.000651	CcSEcCtD
Indinavir—Erythema multiforme—Doxorubicin—uterine cancer	0.00012	0.000645	CcSEcCtD
Indinavir—Malnutrition—Epirubicin—uterine cancer	0.000119	0.000641	CcSEcCtD
Indinavir—Diarrhoea—Etoposide—uterine cancer	0.000119	0.000639	CcSEcCtD
Indinavir—Flushing—Doxorubicin—uterine cancer	0.000118	0.000633	CcSEcCtD
Indinavir—Flatulence—Epirubicin—uterine cancer	0.000118	0.000632	CcSEcCtD
Indinavir—Tension—Epirubicin—uterine cancer	0.000117	0.000629	CcSEcCtD
Indinavir—Dysgeusia—Epirubicin—uterine cancer	0.000117	0.000628	CcSEcCtD
Indinavir—Nervousness—Epirubicin—uterine cancer	0.000116	0.000623	CcSEcCtD
Indinavir—CYP3A5—renal system—uterine cancer	0.000115	0.0276	CbGeAlD
Indinavir—Back pain—Epirubicin—uterine cancer	0.000115	0.00062	CcSEcCtD
Indinavir—Dizziness—Etoposide—uterine cancer	0.000115	0.000618	CcSEcCtD
Indinavir—Muscle spasms—Epirubicin—uterine cancer	0.000115	0.000617	CcSEcCtD
Indinavir—Immune system disorder—Doxorubicin—uterine cancer	0.000114	0.000616	CcSEcCtD
Indinavir—Chills—Doxorubicin—uterine cancer	0.000114	0.000612	CcSEcCtD
Indinavir—Vision blurred—Epirubicin—uterine cancer	0.000112	0.000605	CcSEcCtD
Indinavir—Alopecia—Doxorubicin—uterine cancer	0.000112	0.000602	CcSEcCtD
Indinavir—Ill-defined disorder—Epirubicin—uterine cancer	0.000111	0.000595	CcSEcCtD
Indinavir—Vomiting—Etoposide—uterine cancer	0.00011	0.000594	CcSEcCtD
Indinavir—Malnutrition—Doxorubicin—uterine cancer	0.00011	0.000593	CcSEcCtD
Indinavir—Anaemia—Epirubicin—uterine cancer	0.00011	0.000593	CcSEcCtD
Indinavir—Agitation—Epirubicin—uterine cancer	0.00011	0.000589	CcSEcCtD
Indinavir—Rash—Etoposide—uterine cancer	0.000109	0.000589	CcSEcCtD
Indinavir—ABCC1—female gonad—uterine cancer	0.000109	0.0262	CbGeAlD
Indinavir—Dermatitis—Etoposide—uterine cancer	0.000109	0.000588	CcSEcCtD
Indinavir—Headache—Etoposide—uterine cancer	0.000109	0.000585	CcSEcCtD
Indinavir—ABCC1—vagina—uterine cancer	0.000109	0.026	CbGeAlD
Indinavir—Flatulence—Doxorubicin—uterine cancer	0.000109	0.000585	CcSEcCtD
Indinavir—Tension—Doxorubicin—uterine cancer	0.000108	0.000582	CcSEcCtD
Indinavir—Dysgeusia—Doxorubicin—uterine cancer	0.000108	0.000581	CcSEcCtD
Indinavir—Malaise—Epirubicin—uterine cancer	0.000108	0.000578	CcSEcCtD
Indinavir—Nervousness—Doxorubicin—uterine cancer	0.000107	0.000576	CcSEcCtD
Indinavir—Vertigo—Epirubicin—uterine cancer	0.000107	0.000576	CcSEcCtD
Indinavir—Syncope—Epirubicin—uterine cancer	0.000107	0.000575	CcSEcCtD
Indinavir—Back pain—Doxorubicin—uterine cancer	0.000107	0.000574	CcSEcCtD
Indinavir—Muscle spasms—Doxorubicin—uterine cancer	0.000106	0.000571	CcSEcCtD
Indinavir—CYP2C19—vagina—uterine cancer	0.000106	0.0254	CbGeAlD
Indinavir—Palpitations—Epirubicin—uterine cancer	0.000105	0.000567	CcSEcCtD
Indinavir—Loss of consciousness—Epirubicin—uterine cancer	0.000105	0.000564	CcSEcCtD
Indinavir—Cough—Epirubicin—uterine cancer	0.000104	0.00056	CcSEcCtD
Indinavir—Vision blurred—Doxorubicin—uterine cancer	0.000104	0.000559	CcSEcCtD
Indinavir—Nausea—Etoposide—uterine cancer	0.000103	0.000555	CcSEcCtD
Indinavir—Ill-defined disorder—Doxorubicin—uterine cancer	0.000102	0.000551	CcSEcCtD
Indinavir—Anaemia—Doxorubicin—uterine cancer	0.000102	0.000549	CcSEcCtD
Indinavir—Arthralgia—Epirubicin—uterine cancer	0.000102	0.000546	CcSEcCtD
Indinavir—Chest pain—Epirubicin—uterine cancer	0.000102	0.000546	CcSEcCtD
Indinavir—Myalgia—Epirubicin—uterine cancer	0.000102	0.000546	CcSEcCtD
Indinavir—Agitation—Doxorubicin—uterine cancer	0.000101	0.000545	CcSEcCtD
Indinavir—Anxiety—Epirubicin—uterine cancer	0.000101	0.000544	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000101	0.000542	CcSEcCtD
Indinavir—Discomfort—Epirubicin—uterine cancer	0.0001	0.00054	CcSEcCtD
Indinavir—Malaise—Doxorubicin—uterine cancer	9.95e-05	0.000535	CcSEcCtD
Indinavir—Dry mouth—Epirubicin—uterine cancer	9.93e-05	0.000534	CcSEcCtD
Indinavir—Vertigo—Doxorubicin—uterine cancer	9.91e-05	0.000533	CcSEcCtD
Indinavir—Syncope—Doxorubicin—uterine cancer	9.9e-05	0.000532	CcSEcCtD
Indinavir—Palpitations—Doxorubicin—uterine cancer	9.75e-05	0.000524	CcSEcCtD
Indinavir—Anaphylactic shock—Epirubicin—uterine cancer	9.73e-05	0.000523	CcSEcCtD
Indinavir—Oedema—Epirubicin—uterine cancer	9.73e-05	0.000523	CcSEcCtD
Indinavir—Loss of consciousness—Doxorubicin—uterine cancer	9.7e-05	0.000522	CcSEcCtD
Indinavir—Cough—Doxorubicin—uterine cancer	9.63e-05	0.000518	CcSEcCtD
Indinavir—Shock—Epirubicin—uterine cancer	9.58e-05	0.000515	CcSEcCtD
Indinavir—Nervous system disorder—Epirubicin—uterine cancer	9.55e-05	0.000513	CcSEcCtD
Indinavir—Thrombocytopenia—Epirubicin—uterine cancer	9.53e-05	0.000513	CcSEcCtD
Indinavir—Skin disorder—Epirubicin—uterine cancer	9.45e-05	0.000508	CcSEcCtD
Indinavir—Hyperhidrosis—Epirubicin—uterine cancer	9.41e-05	0.000506	CcSEcCtD
Indinavir—Chest pain—Doxorubicin—uterine cancer	9.39e-05	0.000505	CcSEcCtD
Indinavir—Arthralgia—Doxorubicin—uterine cancer	9.39e-05	0.000505	CcSEcCtD
Indinavir—Myalgia—Doxorubicin—uterine cancer	9.39e-05	0.000505	CcSEcCtD
Indinavir—Anxiety—Doxorubicin—uterine cancer	9.36e-05	0.000504	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	9.33e-05	0.000502	CcSEcCtD
Indinavir—Discomfort—Doxorubicin—uterine cancer	9.28e-05	0.000499	CcSEcCtD
Indinavir—Anorexia—Epirubicin—uterine cancer	9.28e-05	0.000499	CcSEcCtD
Indinavir—Dry mouth—Doxorubicin—uterine cancer	9.19e-05	0.000494	CcSEcCtD
Indinavir—CYP2C9—female reproductive system—uterine cancer	9.09e-05	0.0217	CbGeAlD
Indinavir—Anaphylactic shock—Doxorubicin—uterine cancer	9.01e-05	0.000484	CcSEcCtD
Indinavir—Oedema—Doxorubicin—uterine cancer	9.01e-05	0.000484	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Epirubicin—uterine cancer	8.87e-05	0.000477	CcSEcCtD
Indinavir—Shock—Doxorubicin—uterine cancer	8.86e-05	0.000477	CcSEcCtD
Indinavir—Nervous system disorder—Doxorubicin—uterine cancer	8.83e-05	0.000475	CcSEcCtD
Indinavir—Thrombocytopenia—Doxorubicin—uterine cancer	8.82e-05	0.000474	CcSEcCtD
Indinavir—Insomnia—Epirubicin—uterine cancer	8.8e-05	0.000473	CcSEcCtD
Indinavir—Skin disorder—Doxorubicin—uterine cancer	8.75e-05	0.00047	CcSEcCtD
Indinavir—Paraesthesia—Epirubicin—uterine cancer	8.74e-05	0.00047	CcSEcCtD
Indinavir—Hyperhidrosis—Doxorubicin—uterine cancer	8.71e-05	0.000468	CcSEcCtD
Indinavir—Dyspnoea—Epirubicin—uterine cancer	8.68e-05	0.000467	CcSEcCtD
Indinavir—CYP3A4—renal system—uterine cancer	8.66e-05	0.0207	CbGeAlD
Indinavir—Somnolence—Epirubicin—uterine cancer	8.65e-05	0.000465	CcSEcCtD
Indinavir—Anorexia—Doxorubicin—uterine cancer	8.58e-05	0.000462	CcSEcCtD
Indinavir—Dyspepsia—Epirubicin—uterine cancer	8.57e-05	0.000461	CcSEcCtD
Indinavir—CYP2D6—renal system—uterine cancer	8.52e-05	0.0204	CbGeAlD
Indinavir—Decreased appetite—Epirubicin—uterine cancer	8.46e-05	0.000455	CcSEcCtD
Indinavir—ABCB1—myometrium—uterine cancer	8.42e-05	0.0201	CbGeAlD
Indinavir—CYP3A5—female gonad—uterine cancer	8.41e-05	0.0201	CbGeAlD
Indinavir—Gastrointestinal disorder—Epirubicin—uterine cancer	8.4e-05	0.000452	CcSEcCtD
Indinavir—Fatigue—Epirubicin—uterine cancer	8.39e-05	0.000451	CcSEcCtD
Indinavir—CYP3A5—vagina—uterine cancer	8.36e-05	0.02	CbGeAlD
Indinavir—Constipation—Epirubicin—uterine cancer	8.32e-05	0.000448	CcSEcCtD
Indinavir—Pain—Epirubicin—uterine cancer	8.32e-05	0.000448	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.21e-05	0.000441	CcSEcCtD
Indinavir—Insomnia—Doxorubicin—uterine cancer	8.15e-05	0.000438	CcSEcCtD
Indinavir—Paraesthesia—Doxorubicin—uterine cancer	8.09e-05	0.000435	CcSEcCtD
Indinavir—Dyspnoea—Doxorubicin—uterine cancer	8.03e-05	0.000432	CcSEcCtD
Indinavir—Feeling abnormal—Epirubicin—uterine cancer	8.02e-05	0.000431	CcSEcCtD
Indinavir—Somnolence—Doxorubicin—uterine cancer	8.01e-05	0.000431	CcSEcCtD
Indinavir—ABCC2—lymph node—uterine cancer	7.98e-05	0.0191	CbGeAlD
Indinavir—Gastrointestinal pain—Epirubicin—uterine cancer	7.96e-05	0.000428	CcSEcCtD
Indinavir—Dyspepsia—Doxorubicin—uterine cancer	7.93e-05	0.000426	CcSEcCtD
Indinavir—Decreased appetite—Doxorubicin—uterine cancer	7.83e-05	0.000421	CcSEcCtD
Indinavir—Gastrointestinal disorder—Doxorubicin—uterine cancer	7.78e-05	0.000418	CcSEcCtD
Indinavir—Fatigue—Doxorubicin—uterine cancer	7.76e-05	0.000418	CcSEcCtD
Indinavir—Urticaria—Epirubicin—uterine cancer	7.73e-05	0.000416	CcSEcCtD
Indinavir—Pain—Doxorubicin—uterine cancer	7.7e-05	0.000414	CcSEcCtD
Indinavir—Constipation—Doxorubicin—uterine cancer	7.7e-05	0.000414	CcSEcCtD
Indinavir—Body temperature increased—Epirubicin—uterine cancer	7.69e-05	0.000414	CcSEcCtD
Indinavir—Abdominal pain—Epirubicin—uterine cancer	7.69e-05	0.000414	CcSEcCtD
Indinavir—Feeling abnormal—Doxorubicin—uterine cancer	7.42e-05	0.000399	CcSEcCtD
Indinavir—Gastrointestinal pain—Doxorubicin—uterine cancer	7.36e-05	0.000396	CcSEcCtD
Indinavir—Hypersensitivity—Epirubicin—uterine cancer	7.17e-05	0.000386	CcSEcCtD
Indinavir—Urticaria—Doxorubicin—uterine cancer	7.15e-05	0.000385	CcSEcCtD
Indinavir—Body temperature increased—Doxorubicin—uterine cancer	7.12e-05	0.000383	CcSEcCtD
Indinavir—Abdominal pain—Doxorubicin—uterine cancer	7.12e-05	0.000383	CcSEcCtD
Indinavir—ABCC1—lymph node—uterine cancer	7.03e-05	0.0168	CbGeAlD
Indinavir—Asthenia—Epirubicin—uterine cancer	6.98e-05	0.000376	CcSEcCtD
Indinavir—CYP3A4—female reproductive system—uterine cancer	6.93e-05	0.0166	CbGeAlD
Indinavir—Pruritus—Epirubicin—uterine cancer	6.89e-05	0.00037	CcSEcCtD
Indinavir—CYP2D6—female reproductive system—uterine cancer	6.82e-05	0.0163	CbGeAlD
Indinavir—Diarrhoea—Epirubicin—uterine cancer	6.66e-05	0.000358	CcSEcCtD
Indinavir—Hypersensitivity—Doxorubicin—uterine cancer	6.64e-05	0.000357	CcSEcCtD
Indinavir—ABCB1—epithelium—uterine cancer	6.61e-05	0.0158	CbGeAlD
Indinavir—ABCB1—uterine cervix—uterine cancer	6.55e-05	0.0157	CbGeAlD
Indinavir—Asthenia—Doxorubicin—uterine cancer	6.46e-05	0.000348	CcSEcCtD
Indinavir—Dizziness—Epirubicin—uterine cancer	6.44e-05	0.000346	CcSEcCtD
Indinavir—Pruritus—Doxorubicin—uterine cancer	6.37e-05	0.000343	CcSEcCtD
Indinavir—ABCB1—decidua—uterine cancer	6.24e-05	0.0149	CbGeAlD
Indinavir—CYP2D6—female gonad—uterine cancer	6.21e-05	0.0148	CbGeAlD
Indinavir—Vomiting—Epirubicin—uterine cancer	6.19e-05	0.000333	CcSEcCtD
Indinavir—Diarrhoea—Doxorubicin—uterine cancer	6.16e-05	0.000331	CcSEcCtD
Indinavir—Rash—Epirubicin—uterine cancer	6.14e-05	0.00033	CcSEcCtD
Indinavir—Dermatitis—Epirubicin—uterine cancer	6.13e-05	0.00033	CcSEcCtD
Indinavir—ABCB1—renal system—uterine cancer	6.13e-05	0.0147	CbGeAlD
Indinavir—Headache—Epirubicin—uterine cancer	6.1e-05	0.000328	CcSEcCtD
Indinavir—Dizziness—Doxorubicin—uterine cancer	5.96e-05	0.00032	CcSEcCtD
Indinavir—ABCB1—endometrium—uterine cancer	5.93e-05	0.0142	CbGeAlD
Indinavir—Nausea—Epirubicin—uterine cancer	5.78e-05	0.000311	CcSEcCtD
Indinavir—ABCB1—mammalian vulva—uterine cancer	5.73e-05	0.0137	CbGeAlD
Indinavir—Vomiting—Doxorubicin—uterine cancer	5.73e-05	0.000308	CcSEcCtD
Indinavir—Rash—Doxorubicin—uterine cancer	5.68e-05	0.000305	CcSEcCtD
Indinavir—Dermatitis—Doxorubicin—uterine cancer	5.67e-05	0.000305	CcSEcCtD
Indinavir—Headache—Doxorubicin—uterine cancer	5.64e-05	0.000303	CcSEcCtD
Indinavir—ABCB1—uterus—uterine cancer	5.46e-05	0.0131	CbGeAlD
Indinavir—Nausea—Doxorubicin—uterine cancer	5.35e-05	0.000288	CcSEcCtD
Indinavir—ABCB1—female reproductive system—uterine cancer	4.91e-05	0.0117	CbGeAlD
Indinavir—ABCB1—female gonad—uterine cancer	4.47e-05	0.0107	CbGeAlD
Indinavir—ABCB1—vagina—uterine cancer	4.44e-05	0.0106	CbGeAlD
Indinavir—ABCB1—lymph node—uterine cancer	2.87e-05	0.00687	CbGeAlD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	7.09e-06	0.00186	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	7.09e-06	0.00186	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	7.05e-06	0.00185	CbGpPWpGaD
Indinavir—ABCC1—Disease—RNF43—uterine cancer	6.89e-06	0.00181	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—CXCL8—uterine cancer	6.87e-06	0.00181	CbGpPWpGaD
Indinavir—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	6.8e-06	0.00179	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	6.64e-06	0.00175	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	6.58e-06	0.00173	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	6.55e-06	0.00172	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	6.54e-06	0.00172	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKR1B1—uterine cancer	6.48e-06	0.0017	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—STAR—uterine cancer	6.48e-06	0.0017	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.46e-06	0.0017	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.46e-06	0.0017	CbGpPWpGaD
Indinavir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	6.44e-06	0.00169	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.4e-06	0.00168	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	6.19e-06	0.00163	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKR1B1—uterine cancer	6.15e-06	0.00162	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—STAR—uterine cancer	6.15e-06	0.00162	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	6.08e-06	0.0016	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKR1C1—uterine cancer	5.68e-06	0.00149	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—STAR—uterine cancer	5.65e-06	0.00148	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKR1B1—uterine cancer	5.65e-06	0.00148	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—POLD1—uterine cancer	5.65e-06	0.00148	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—SRD5A2—uterine cancer	5.65e-06	0.00148	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—NDUFB11—uterine cancer	5.65e-06	0.00148	CbGpPWpGaD
Indinavir—ABCB1—Allograft Rejection—VEGFA—uterine cancer	5.58e-06	0.00147	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKR1C1—uterine cancer	5.28e-06	0.00139	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—STAR—uterine cancer	5.26e-06	0.00138	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKR1B1—uterine cancer	5.26e-06	0.00138	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.2e-06	0.00137	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—POLD1—uterine cancer	5.08e-06	0.00134	CbGpPWpGaD
Indinavir—ABCC1—Disease—DCN—uterine cancer	4.91e-06	0.00129	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	4.89e-06	0.00128	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	4.87e-06	0.00128	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—POLD1—uterine cancer	4.83e-06	0.00127	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	4.82e-06	0.00127	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKR1C1—uterine cancer	4.75e-06	0.00125	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.74e-06	0.00125	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—RRM2—uterine cancer	4.71e-06	0.00124	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—DCN—uterine cancer	4.57e-06	0.0012	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKR1C1—uterine cancer	4.52e-06	0.00119	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—POLD1—uterine cancer	4.43e-06	0.00117	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKR1C3—uterine cancer	4.37e-06	0.00115	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—SRD5A2—uterine cancer	4.37e-06	0.00115	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—NDUFB11—uterine cancer	4.37e-06	0.00115	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP11A1—uterine cancer	4.31e-06	0.00113	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—SRD5A2—uterine cancer	4.26e-06	0.00112	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—NDUFB11—uterine cancer	4.26e-06	0.00112	CbGpPWpGaD
Indinavir—ABCC1—Disease—HMGA1—uterine cancer	4.26e-06	0.00112	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.24e-06	0.00111	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—RRM2—uterine cancer	4.24e-06	0.00111	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKR1C1—uterine cancer	4.15e-06	0.00109	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—POLD1—uterine cancer	4.13e-06	0.00108	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—DCN—uterine cancer	4.11e-06	0.00108	CbGpPWpGaD
Indinavir—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.11e-06	0.00108	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKR1B1—uterine cancer	4.08e-06	0.00107	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—STAR—uterine cancer	4.08e-06	0.00107	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKR1C3—uterine cancer	4.07e-06	0.00107	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—RRM2—uterine cancer	4.03e-06	0.00106	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—SRD5A2—uterine cancer	4.02e-06	0.00106	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—NDUFB11—uterine cancer	4.02e-06	0.00106	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.01e-06	0.00105	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—SRD5A2—uterine cancer	3.98e-06	0.00105	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—NDUFB11—uterine cancer	3.98e-06	0.00105	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—DCN—uterine cancer	3.91e-06	0.00103	CbGpPWpGaD
Indinavir—ABCC1—Disease—FBXW7—uterine cancer	3.89e-06	0.00102	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP11A1—uterine cancer	3.88e-06	0.00102	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.87e-06	0.00102	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKR1C1—uterine cancer	3.86e-06	0.00101	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—RRM2—uterine cancer	3.7e-06	0.000971	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP11A1—uterine cancer	3.68e-06	0.000968	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKR1C3—uterine cancer	3.66e-06	0.000962	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.65e-06	0.00096	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—DCN—uterine cancer	3.59e-06	0.000943	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.58e-06	0.00094	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKR1C3—uterine cancer	3.48e-06	0.000914	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—RRM2—uterine cancer	3.44e-06	0.000904	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP11A1—uterine cancer	3.38e-06	0.000888	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—DCN—uterine cancer	3.34e-06	0.000878	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	3.31e-06	0.00087	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	3.27e-06	0.00086	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—POLD1—uterine cancer	3.2e-06	0.000842	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKR1C3—uterine cancer	3.19e-06	0.000839	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—STK11—uterine cancer	3.17e-06	0.000833	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP19A1—uterine cancer	3.17e-06	0.000833	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—STAR—uterine cancer	3.16e-06	0.00083	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKR1B1—uterine cancer	3.16e-06	0.00083	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP11A1—uterine cancer	3.15e-06	0.000827	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.13e-06	0.000822	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.12e-06	0.00082	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKR1B1—uterine cancer	3.08e-06	0.00081	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—STAR—uterine cancer	3.08e-06	0.00081	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN2B—uterine cancer	3.05e-06	0.000802	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.05e-06	0.000801	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKR1C1—uterine cancer	3e-06	0.000788	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.97e-06	0.000782	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKR1C3—uterine cancer	2.97e-06	0.000781	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.91e-06	0.000764	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.9e-06	0.000763	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—STAR—uterine cancer	2.9e-06	0.000763	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.88e-06	0.000757	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—STAR—uterine cancer	2.88e-06	0.000757	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—STK11—uterine cancer	2.85e-06	0.000749	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP19A1—uterine cancer	2.85e-06	0.000749	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.85e-06	0.000748	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.84e-06	0.000746	CbGpPWpGaD
Indinavir—ABCC1—Disease—SMAD3—uterine cancer	2.79e-06	0.000732	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.75e-06	0.000724	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP19A1—uterine cancer	2.71e-06	0.000712	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—STK11—uterine cancer	2.71e-06	0.000712	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.68e-06	0.000703	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—RRM2—uterine cancer	2.67e-06	0.000702	CbGpPWpGaD
Indinavir—ABCC1—Disease—FGFR2—uterine cancer	2.66e-06	0.000699	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.63e-06	0.00069	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.63e-06	0.00069	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—DCN—uterine cancer	2.59e-06	0.000682	CbGpPWpGaD
Indinavir—ABCC1—Disease—MTHFR—uterine cancer	2.56e-06	0.000672	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.55e-06	0.000671	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.54e-06	0.000668	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—HRAS—uterine cancer	2.51e-06	0.000659	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—STK11—uterine cancer	2.49e-06	0.000654	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP19A1—uterine cancer	2.49e-06	0.000654	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—POLD1—uterine cancer	2.48e-06	0.000651	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP11A1—uterine cancer	2.44e-06	0.000642	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.43e-06	0.000638	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—POLD1—uterine cancer	2.42e-06	0.000636	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—MTHFR—uterine cancer	2.38e-06	0.000626	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.34e-06	0.000615	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKR1C1—uterine cancer	2.32e-06	0.000609	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—STK11—uterine cancer	2.31e-06	0.000608	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP19A1—uterine cancer	2.31e-06	0.000608	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKR1C3—uterine cancer	2.31e-06	0.000606	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—POLD1—uterine cancer	2.28e-06	0.000599	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKR1C1—uterine cancer	2.26e-06	0.000594	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—POLD1—uterine cancer	2.26e-06	0.000594	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.15e-06	0.000565	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—MTHFR—uterine cancer	2.14e-06	0.000563	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKR1C1—uterine cancer	2.13e-06	0.00056	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.11e-06	0.000555	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.1e-06	0.000551	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.08e-06	0.000547	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—RRM2—uterine cancer	2.07e-06	0.000543	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—MTHFR—uterine cancer	2.04e-06	0.000535	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—RRM2—uterine cancer	2.02e-06	0.00053	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—DCN—uterine cancer	2e-06	0.000527	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—DCN—uterine cancer	1.96e-06	0.000514	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—RRM2—uterine cancer	1.9e-06	0.000499	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—STAR—uterine cancer	1.9e-06	0.000499	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.9e-06	0.000499	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.89e-06	0.000496	CbGpPWpGaD
Indinavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.89e-06	0.000496	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—RRM2—uterine cancer	1.88e-06	0.000495	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—MTHFR—uterine cancer	1.87e-06	0.000491	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—DCN—uterine cancer	1.84e-06	0.000485	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP11A1—uterine cancer	1.84e-06	0.000485	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—DCN—uterine cancer	1.83e-06	0.00048	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.8e-06	0.000472	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—STK11—uterine cancer	1.8e-06	0.000472	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.79e-06	0.000472	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.78e-06	0.000469	CbGpPWpGaD
Indinavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.76e-06	0.000462	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKR1C3—uterine cancer	1.74e-06	0.000458	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—MTHFR—uterine cancer	1.74e-06	0.000457	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.74e-06	0.000457	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.72e-06	0.000453	CbGpPWpGaD
Indinavir—ABCC1—Disease—ERBB2—uterine cancer	1.67e-06	0.000439	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.64e-06	0.000431	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.63e-06	0.000428	CbGpPWpGaD
Indinavir—ABCC1—Disease—CDKN1B—uterine cancer	1.55e-06	0.000406	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—POLD1—uterine cancer	1.49e-06	0.000392	CbGpPWpGaD
Indinavir—ABCC1—Disease—CTNNB1—uterine cancer	1.46e-06	0.000384	CbGpPWpGaD
Indinavir—ABCC1—Disease—PTEN—uterine cancer	1.42e-06	0.000374	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.39e-06	0.000366	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—STK11—uterine cancer	1.39e-06	0.000365	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.39e-06	0.000365	CbGpPWpGaD
Indinavir—ABCC1—Disease—EP300—uterine cancer	1.36e-06	0.000357	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—STK11—uterine cancer	1.36e-06	0.000357	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP19A1—uterine cancer	1.36e-06	0.000357	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—MTHFR—uterine cancer	1.35e-06	0.000355	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PTEN—uterine cancer	1.32e-06	0.000348	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.3e-06	0.000343	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—STK11—uterine cancer	1.28e-06	0.000336	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP19A1—uterine cancer	1.28e-06	0.000336	CbGpPWpGaD
Indinavir—ABCC1—Disease—NRAS—uterine cancer	1.27e-06	0.000334	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—STK11—uterine cancer	1.27e-06	0.000333	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.27e-06	0.000333	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—EP300—uterine cancer	1.26e-06	0.000332	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.24e-06	0.000327	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—RRM2—uterine cancer	1.24e-06	0.000326	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—DCN—uterine cancer	1.21e-06	0.000317	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PTEN—uterine cancer	1.19e-06	0.000313	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.19e-06	0.000313	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—EP300—uterine cancer	1.14e-06	0.000299	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.14e-06	0.000299	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.13e-06	0.000298	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PTEN—uterine cancer	1.13e-06	0.000298	CbGpPWpGaD
Indinavir—ABCC1—Disease—KRAS—uterine cancer	1.09e-06	0.000287	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—EP300—uterine cancer	1.08e-06	0.000284	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.07e-06	0.000282	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—MTHFR—uterine cancer	1.04e-06	0.000274	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PTEN—uterine cancer	1.04e-06	0.000273	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—MTHFR—uterine cancer	1.02e-06	0.000268	CbGpPWpGaD
Indinavir—ABCC1—Disease—PIK3CA—uterine cancer	1e-06	0.000264	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—EP300—uterine cancer	9.91e-07	0.000261	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PTEN—uterine cancer	9.67e-07	0.000254	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—MTHFR—uterine cancer	9.6e-07	0.000252	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—MTHFR—uterine cancer	9.52e-07	0.00025	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—PIK3CA—uterine cancer	9.34e-07	0.000246	CbGpPWpGaD
Indinavir—ABCC1—Disease—HRAS—uterine cancer	9.29e-07	0.000244	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—EP300—uterine cancer	9.23e-07	0.000242	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.2e-07	0.000242	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—PIK3CA—uterine cancer	8.41e-07	0.000221	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.39e-07	0.000221	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—STK11—uterine cancer	8.36e-07	0.00022	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP19A1—uterine cancer	8.36e-07	0.00022	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKT1—uterine cancer	8.2e-07	0.000216	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—PIK3CA—uterine cancer	7.99e-07	0.00021	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—AKT1—uterine cancer	7.63e-07	0.000201	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PTEN—uterine cancer	7.51e-07	0.000198	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—PIK3CA—uterine cancer	7.33e-07	0.000193	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—EP300—uterine cancer	7.17e-07	0.000188	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—AKT1—uterine cancer	6.87e-07	0.000181	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—PIK3CA—uterine cancer	6.82e-07	0.000179	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—AKT1—uterine cancer	6.53e-07	0.000172	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—MTHFR—uterine cancer	6.28e-07	0.000165	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—AKT1—uterine cancer	5.99e-07	0.000157	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PTEN—uterine cancer	5.81e-07	0.000153	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PTEN—uterine cancer	5.67e-07	0.000149	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—AKT1—uterine cancer	5.58e-07	0.000147	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—EP300—uterine cancer	5.54e-07	0.000146	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—EP300—uterine cancer	5.41e-07	0.000142	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PTEN—uterine cancer	5.34e-07	0.00014	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—PIK3CA—uterine cancer	5.3e-07	0.000139	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PTEN—uterine cancer	5.3e-07	0.000139	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—EP300—uterine cancer	5.1e-07	0.000134	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—EP300—uterine cancer	5.05e-07	0.000133	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—AKT1—uterine cancer	4.33e-07	0.000114	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—PIK3CA—uterine cancer	4.1e-07	0.000108	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—PIK3CA—uterine cancer	4e-07	0.000105	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—PIK3CA—uterine cancer	3.77e-07	9.91e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—PIK3CA—uterine cancer	3.74e-07	9.82e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PTEN—uterine cancer	3.49e-07	9.18e-05	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—AKT1—uterine cancer	3.35e-07	8.8e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—EP300—uterine cancer	3.33e-07	8.76e-05	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—AKT1—uterine cancer	3.27e-07	8.59e-05	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—AKT1—uterine cancer	3.08e-07	8.09e-05	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—AKT1—uterine cancer	3.05e-07	8.02e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—PIK3CA—uterine cancer	2.46e-07	6.48e-05	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—AKT1—uterine cancer	2.01e-07	5.29e-05	CbGpPWpGaD
